HIGH ALERT: Please read the COMMENTS very carefully.
rituximab
Preferred biosimilar agent for Inpatient and Outpatient use: Ruxience (-pvvr)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).
Preferred biosimilar agent for Inpatient and Outpatient use: Ruxience (-pvvr)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).